May 2016—Horizon Discovery Group introduced its microinjection-ready Cas9 Accelerate Ribonucleoprotein. Cas9 Accelerate RNP maximizes gene-editing efficiency by enabling CRISPR …
Read More »Home >> Tag Archives: Horizon Diagnostics
Collaboration to develop cfDNA reference standards, 8/15
CareDx and Horizon Discovery Group will collaborate to develop cell-free DNA reference standards. The HDx Reference standards, being developed by Horizon Diagnostics, will support proficiency testing of CareDx’s solid organ transplant injury monitoring diagnostic tests and will be integrated into CLIA laboratory testing.
Read More »